{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:11:17Z","timestamp":1791353477090,"version":"4.3.1"},"publisher-location":"Chichester, UK","reference-count":79,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003553.pub2","type":"reference-entry","created":{"date-parts":[[2006,8,11]],"date-time":"2006-08-11T00:59:30Z","timestamp":1155257970000},"source":"Crossref","is-referenced-by-count":17,"title":["Triphasic versus monophasic oral contraceptives for contraception"],"prefix":"10.1002","author":[{"given":"Huib AAM","family":"Van Vliet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen M","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"10.1002\/14651858.CD003553.pub2-BIB1|cit1","unstructured":"Agoestina T Sulaeman M Rarung M Sabarudin U Clinical evaluation of low dose pill triphasic (EE + estoden) versus monophasic (EE + desogestrel) Presented at the XIth Asian and Oceanic Congress of Obstetrics and Gynecology; 1987 Dec 6-12; Hongkong"},{"issue":"Suppl","key":"10.1002\/14651858.CD003553.pub2-BIB2|cit2","first-page":"33","article-title":"Clinical comparison of a triphasic gestodene preparation and a monophasic desogestrel preparation","volume":"7","author":"Andrade","year":"1993","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09513590009167666","article-title":"A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives","volume":"14","author":"Bruni","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD003553.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/09513599609049607","article-title":"A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives","volume":"10","author":"Lacante","year":"1996","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB5|cit5","series-title":"Benefits and risk of hormonal contraception: Proceedings of an International Symposium; 1982 March 19; Amsterdam","first-page":"78","article-title":"Acceptability of low-dose oral contraceptives: results of a randomized Swedish multicenter study comparing a triphasic (Trionetta) and a fixed-dose combination (Neovletta)","author":"Carlborg","year":"1982"},{"key":"10.1002\/14651858.CD003553.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0010-7824(83)90041-0","article-title":"Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version","volume":"27","author":"Carlborg","year":"1983","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/13625189909064008","article-title":"A comparison of cycle control with monophasic levonorgestrel\/ethinylestradiol 100 micrograms\/20 micrograms versus triphasic norethindrone\/ethinylestradiol 500-750-1000 micrograms\/35 micrograms: a multicenter, randomized, open-label study","volume":"4","author":"Chavez","year":"1999","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD003553.pub2-BIB8|cit8","first-page":"11","article-title":"A comparative clinical study of the effects of three types of low dose estrogen\/progestogen oral contraceptives","volume":"7","author":"Chen","year":"1987","journal-title":"Reproduction and Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB9|cit9","first-page":"11","article-title":"A comparative clinical study of the effects of three types of low-dose estrogen\/progestogen oral contraceptives","volume":"7","author":"Chen","year":"1987","journal-title":"Shengzhi Yu Biyun"},{"key":"10.1002\/14651858.CD003553.pub2-BIB11|cit10","first-page":"97","article-title":"A comparative multicentre study on a triphasic, and a fixed low-dose oral contraceptive combination","volume":"Suppl 116","author":"Cullberg","year":"1983","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD003553.pub2-BIB10|cit11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0010-7824(82)90072-5","article-title":"Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination","volume":"26","author":"Cullberg","year":"1982","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB12|cit12","first-page":"16","article-title":"A comparative study of the clinical efficacy of Marvelon and a triphasic combination","volume":"21","author":"Dieben","year":"1984","journal-title":"Organorama"},{"key":"10.1002\/14651858.CD003553.pub2-BIB13|cit13","first-page":"43","article-title":"Clinical and metabolic effects of Marvelon: Scandinavian experience","volume":"10","author":"Mattsson","year":"1984","journal-title":"British Journal of Family Planning"},{"key":"10.1002\/14651858.CD003553.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0010-7824(93)90020-8","article-title":"A multicenter comparative trial of triphasic and monophasic, low dose combined oral contraceptives","volume":"47","author":"Dunson","year":"1993","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB15|cit15","first-page":"941","article-title":"Triphasic versus monophasic p-pill. A comparative multicenter study","volume":"107","author":"Engebretsen","year":"1987","journal-title":"Tidsskrift for den Norske Laegeforening"},{"key":"10.1002\/14651858.CD003553.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0010-7824(01)00214-1","article-title":"Comparison of a novel norgestimate\/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1\/20","volume":"63","author":"Hampton","year":"2001","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2008.02.007","article-title":"Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives","volume":"77","author":"Hampton","year":"2008","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB18|cit18","first-page":"9","article-title":"A randomised comparative study of Triquilar versus Marvelon: the Malaysian experience","volume":"9","author":"Ismail","year":"1991","journal-title":"Malaysian Journal of Reproductive Health"},{"key":"10.1002\/14651858.CD003553.pub2-BIB20|cit19","first-page":"825","article-title":"Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations","volume":"102","author":"Lachnit-Fixson","year":"1984","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD003553.pub2-BIB19|cit20","first-page":"71","article-title":"Clinical comparison between a monophasic preparation and a triphasic preparation","volume-title":"Advances in fertility control and the treatment of sterility. Proceedings of a special symposium held at the XIth world congress on fertility and sterility; 1983 June; Dublin","author":"Lachnit-Fixson","year":"1984"},{"key":"10.1002\/14651858.CD003553.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(90)90013-L","article-title":"Cycle control on low-dose oral contraceptives: a comparative trial","volume":"42","author":"Percival-Smith","year":"1990","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0010-7824(89)80005-8","article-title":"A comparative analysis of three different dose combinations of oral contraceptives","volume":"39","author":"Ramos","year":"1989","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0002-9378(99)70363-7","article-title":"A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 \u03bcg levonorgestrel with 20 \u03bcg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol","volume":"181","author":"Reisman","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB24|cit24","first-page":"547","article-title":"Initial selection of oral contraceptives","volume":"35","author":"Reiter","year":"1990","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD003553.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 \u03bcg and 35 \u03bcg estrogen preperations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-9378(99)70722-2","article-title":"\"Estrophasic\" dosing: A new concept in oral contraceptive therapy","volume":"180","author":"Rowan","year":"1999","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0010-7824(95)00012-Y","article-title":"Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)-an Indian experience","volume":"51","author":"Datey","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB28|cit28","first-page":"71","article-title":"Randomised clinical trial with Triquilar-ED and low-dose combination pill","volume":"42","author":"Saxena","year":"1992","journal-title":"Journal of Obstetrics and Gynaecology of India"},{"issue":"Suppl","key":"10.1002\/14651858.CD003553.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0029-7844(99)90079-0","article-title":"A clinical comparison of two oral contraceptives: triphasic norgestimate\/35 \u03bcg ethinylestradiol versus monophasic norethindrone acetate\/20 \u03bcg ethinylestradiol","volume":"93","author":"Lippman","year":"1999","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00026-8","article-title":"Clinical comparison of triphasic norgestimate\/35 \u03bcg ethinyl estradiol and monophasic norethindrone acetate\/20 \u03bcg ethinyl estradiol: cycle control, lipid effects, and user satisfaction","volume":"59","author":"Sulak","year":"1999","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB31|cit31","first-page":"99","article-title":"Clinical investigation with a new triphasic oral contraceptive","volume-title":"The development of a new triphasic oral contraceptive. Proceedings of a Special Symposium held at the 10th World Congress on Fertility and Sterility; 1980 July; Madrid","author":"Lachnit-Fixson","year":"1980"},{"key":"10.1002\/14651858.CD003553.pub2-BIB32|cit32","first-page":"825","article-title":"Progress in oral contraception. Advantages of a levonorgestrel-containing 3-stage preparation over low-dose levonorgestrel and desogestrel containing monophasic combination preparations","volume":"102","author":"Lachnit-Fixson","year":"1984","journal-title":"Fortschritte der Medizin"},{"key":"10.1002\/14651858.CD003553.pub2-BIB33|cit33","first-page":"1421","article-title":"The first three-stage preparation for hormonal contraception. Clinical results","volume":"121","author":"Lachnit-Fixson","year":"1979","journal-title":"Munchener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD003553.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-94-011-6675-1_5","article-title":"Clinical performance of a triphasic administration of ethinyl estradiol and levonorgestrel in comparison with the 30 + 150 \u03bcg fixed-dose regimen","volume-title":"Benefits and risk of hormonal contraception. Proceedings of an international symposium; 1982 March 19; Amsterdam","author":"Zador","year":"1982"},{"key":"10.1002\/14651858.CD003553.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00016347909157228","article-title":"Fertility regulation using \"triphasic\" administration of ethinyl estradiol and levonorgestrel in comparison with the 30 plus 150 \u03bcg fixed dose regime","volume":"88","author":"Zador","year":"1979","journal-title":"Acta Obstetricia et Gynecologica Scandinavica. Supplement"},{"key":"10.1002\/14651858.CD003553.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01674828709019585","article-title":"The effects of oral contraceptives on mood and sexuality: A comparison of triphasic and combined preparations","volume":"7","author":"Bancroft","year":"1987","journal-title":"Journal of Psychosomatic Obstetrics and Gynaecology"},{"issue":"Suppl","key":"10.1002\/14651858.CD003553.pub2-BIB37|cit37","first-page":"40","article-title":"A clinical overview of a new triphasic contraceptive containing gestodene","volume":"34","author":"Christie","year":"1989","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD003553.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1055\/s-2008-1036524","article-title":"Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)","volume":"44","author":"Dik","year":"1984","journal-title":"Geburtshilfe und Frauenheilkunde"},{"key":"10.1002\/14651858.CD003553.pub2-BIB39|cit39","first-page":"47","article-title":"Acceptability of hormonal contraceptives with a low steroid content","volume":"8","author":"Dubnitskaia","year":"1988","journal-title":"Akusherstvo I Ginekologiia"},{"key":"10.1002\/14651858.CD003553.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0932-8610(12)80175-7","article-title":"Contraceptive compliance with a triphasic and a monophasic norethindrone-containing oral contraceptive pill in a private adolescent practice","volume":"7","author":"Grace","year":"1994","journal-title":"Adolescent and Pediatric Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(85)90058-7","article-title":"A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: 1. Effects upon sexual hormone levels","volume":"31","author":"Kuhl","year":"1985","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB42|cit42","first-page":"165","article-title":"Results of a clinical study with low-dose oral contraceptives: investigation with triphasic and monophasic preparations containing levonorgestrel and ethinylestradiol","volume":"44","author":"Matsumoto","year":"1988","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD003553.pub2-BIB43|cit43","first-page":"116","article-title":"Clinical experience with a triphasic oral contraceptive containing ethinyloestradiol and levonorgestrel in Nigerian women","volume":"8","author":"Otolorin","year":"1989","journal-title":"West African Journal of Medicine"},{"key":"10.1002\/14651858.CD003553.pub2-BIB44|cit44","first-page":"6","article-title":"Oral contraceptives and their minor side effects: comparison of three low-dose estroprogestinic combinations","volume":"15","author":"Perrone","year":"1987","journal-title":"Patologia e Clinica Ostetrica e Ginecologica"},{"key":"10.1002\/14651858.CD003553.pub2-BIB45|cit45","first-page":"75","article-title":"Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5 year experience","volume":"8","author":"Rubio-Lotvin","year":"1992","journal-title":"Advances in Contraceptive Delivery Systems"},{"key":"10.1002\/14651858.CD003553.pub2-BIB46|cit46","unstructured":"Bayer Schering Pharma AG Cycle Control and Safety of E2-DRSP Available from: http:\/\/clinicaltrials.gov\/ct2\/home"},{"key":"10.1002\/14651858.CD003553.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.290.7.921","article-title":"Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?","volume":"290","author":"Als-Nielsen","year":"2003","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003553.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(05)62352-5","article-title":"Does blinding of readers affect the results of meta-analyses?","volume":"350","author":"Berlin","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJM198206033062204","article-title":"Reporting on methods in clinical trials","volume":"306","author":"DerSimonian","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003553.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bmj.284.6308.17-a","article-title":"Failure with the new triphasic oral contraceptive Logynon","volume":"284","author":"Fay","year":"1982","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD003553.pub2-BIB52|cit52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub3","article-title":"20 \u03bcg versus >20 \u03bcg estrogen combined oral contraceptives for contraception","author":"Gallo","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003553.pub2-BIB53|cit53","first-page":"422","article-title":"Failure with the new triphasic oral contraceptive Logynon","volume":"284","author":"Graham","year":"1982","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD003553.pub2-BIB54|cit54","first-page":"188","volume-title":"Contraception: your questions answered","author":"Guillebaud","year":"1993"},{"key":"10.1002\/14651858.CD003553.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0002-9378(87)80131-X","article-title":"Phasic approach to oral contraceptives","volume":"157","author":"Hale","year":"1987","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB56|cit56","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] In: The Cochrane Library 2005, Issue 3. Chichester, UK: John Wiley & Sons, Ltd"},{"key":"10.1002\/14651858.CD003553.pub2-BIB57|cit57","unstructured":"World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) http:\/\/www.who.int\/ictrp\/search\/en\/"},{"key":"10.1002\/14651858.CD003553.pub2-BIB58|cit58","volume-title":"Medical and Service Delivery Guidelines for Sexual and Reproductive Health Services","author":"Terki","year":"2004"},{"key":"10.1002\/14651858.CD003553.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis","volume":"282","author":"Juni","year":"1999","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003553.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0010-7824(88)90111-4","article-title":"The relative reliability of oral contraceptives: findings of an epidemiological study","volume":"37","author":"Ketting","year":"1988","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"549","DOI":"10.5694\/j.1326-5377.1989.tb136691.x","article-title":"Inadvertent pregnancies in oral contraceptive users","volume":"150","author":"Kovacs","year":"1989","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD003553.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD003553.pub2-BIB63|cit63","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004861","article-title":"Progestogens in combined oral contraceptives for contraception","author":"Maitra","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003553.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials","volume":"14","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.AOG.0000260956.61835.6d","article-title":"Oral contraceptive tolerance. Does the type of pill matter?","volume":"109","author":"Moreau","year":"2007","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB66|cit66","unstructured":"US National Institutes of Health (NIH) ClinicalTrials.gov http:\/\/clinicaltrials.gov\/ct2\/home"},{"issue":"Suppl","key":"10.1002\/14651858.CD003553.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01849449","article-title":"Oral contraceptives and cycle control: a critical review of the literature","volume":"8","author":"Rosenberg","year":"1992","journal-title":"Advances in Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD003553.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003553.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003553.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7326\/0003-4819-136-3-200202050-00022","article-title":"The landscape and lexicon of blinding in randomized trials","volume":"136","author":"Schulz","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003553.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","article-title":"Generation of allocation sequences in randomised trials: chance, not choice","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(02)07750-4","article-title":"Allocation concealment in randomised trials: defending against deciphering","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003553.pub2-BIB76|cit76","volume-title":"Evidence-based Medicine: How to Practice and Teach EBM","author":"Strauss","year":"2005"},{"key":"10.1002\/14651858.CD003553.pub2-BIB77|cit77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/sim.4780100206","article-title":"Methodological pitfalls in the analysis of contraceptive failure","volume":"10","author":"Trussell","year":"1991","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003553.pub2-BIB78|cit78","first-page":"121","article-title":"The phasic approach to oral contraception:the triphasic concept and its clinical application","volume":"28","author":"Upton","year":"1983","journal-title":"International Journal of Fertility"},{"key":"10.1002\/14651858.CD003553.pub2-BIB79|cit79","volume-title":"Causes of venous thrombosis: procoagulant factors and oral contraceptives [dissertation]","author":"Hylckama Vlieg","year":"2003"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003553.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,11,9]],"date-time":"2011-11-09T00:00:00Z","timestamp":1320796800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003553.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:22:36Z","timestamp":1628544156000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003553.pub2"}},"subtitle":[],"editor":[{"given":"Huib AAM","family":"Van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":79,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003553.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003553.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,7,19]]}}}